Colin L. Masters
155 Oak Street
Parkville, VIC 3052, Australia
Parkville, VIC 3052, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 591 publications
Creutzfeldt-Jakob disease surveillance in Australia: update to 31 December 2025.
Journal: Communicable diseases intelligence (2018)
Published: July 20, 2026
Amyloid PET Quantitation and Centiloid Thresholds in the Diagnosis of Alzheimer Disease: An Individual Participant Data Meta-Analysis.
Journal: JAMA
Published: July 13, 2026
Comparing Pathway-Informed Polygenic Risk Score Strategies: A multi-cohort evaluation of Amyloid-β.
Journal: medRxiv : the preprint server for health sciences
Published: June 05, 2026
Composite scores to detect and monitor cognitive dysfunction in preclinical and prodromal Alzheimer's disease: A narrative review.
Journal: Journal of Alzheimer's disease : JAD
Published: March 23, 2026
Discovery of lipid biomarkers for idiopathic Parkinson's disease in red blood cells and plasma.
Journal: NPJ Parkinson's disease
Published: March 19, 2026
Could the cognitive benefits of amyloid-beta clearance grow in time for Alzheimer's disease?
Journal: Translational psychiatry
Published: January 23, 2026
The P2X7 Receptor in Cancer: From Functional Receptor to Non-Functional P2X7.
Journal: Carcinogenesis
Published: January 20, 2026
Plasma proteome profiling identified biomarkers for the differential diagnosis and molecular staging of neurodegenerative dementias.
Journal: Nature aging
Published: January 05, 2026
A phase 2, randomized, multicenter, double-blind, placebo-controlled trial of S-adenosyl methionine in participants with mild cognitive impairment or dementia due to Alzheimer's disease.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: December 15, 2025
Functional Pathways of the Gut Microbiome Associated with SCFA Profiles in Preclinical Alzheimer's Disease.
Journal: Aging and disease
Published: December 12, 2025
Plasma soluble TREM2 is associated with plasma pTau-181 and pTau-231 in cognitively normal older adults at risk of Alzheimer's disease.
Journal: Journal of Alzheimer's disease : JAD
Published: December 09, 2025
Last Updated: 09/26/2026